The Fund supports networks of state health policy decision makers to help identify, inspire, and inform policy leaders.
The Milbank Memorial Fund supports two state leadership programs for legislative and executive branch state government officials committed to improving population health.
The Fund identifies and shares policy ideas and analysis to advance state health leadership, strong primary care, and sustainable health care costs.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is is a foundation that works to improve population health and health equity.
April 2, 2025
Quarterly Article
Brendan Saloner
March 2025
December 2024
September 2024
Back to The Milbank Quarterly
Policy Points:
This Perspective examines the role of Medicaid in the innovation of substance use disorder (SUD) treatment. In 2023, an estimated 49 million Americans met criteria for an SUD and more than 100,000 people died of a drug overdose.1, 2 Compared with the general population, people with SUD experience worse self-rated health, a higher burden of other chronic diseases, and more hospital care.3, 4 The social and economic consequences of SUD are also pervasive.5, 6 People with SUD are much more likely to be involved with the criminal legal system, unhoused, and unemployed than the general population.7 With treatment, SUD symptoms are just as manageable as other chronic diseases like diabetes, asthma, and hypertension.8 In spite of these benefits, only one-quarter of people with SUD receive treatment in any year.1 Furthermore, treatment is often too limited in its scope and duration to be effective. Many people discontinue care before achieving meaningful benefits.7